Brakes India Private Limited

Brakes India has delivered strong compounding growth over FY2021–FY2025, with revenue expanding from ₹3,876 Cr to ₹7,499 Cr — a 17.9% CAGR 2 — driven by recovery in domestic OEM volumes and export ramp-up. Growth decelerated sharply from +29.7% in FY2023 to +0.2% in FY2025 13, signalling a maturing top-line cycle. Margin expansion was a more compelling story: EBITDA margin widened from 10.9% (FY2021) to a peak of 15.1% (FY2024) before retracing to 13.6% in FY2025 7, with PAT margin peaking at 9.9% in FY2024 8. PAT compounded at 32.3% CAGR over the same period 4, materially outpacing revenue growth — a testament to operating leverage. Return ratios tracked this arc: ROCE reached 27.0% in FY2024 before moderating to 21.5% in FY2025 11, while ROE followed a similar path from 24.9% to 19.3% 10. The FY2025 moderation reflects cost pressures rather than structural deterioration; interest coverage of 17.5x 16 confirms robust debt-service capacity heading into the next phase of capital deployment.

Brakes India's governance framework reflects the multi-generational stewardship of the TSF Group, whose heritage dates to 1936 6, with executive leadership concentrated in a compact but experienced team. Sriram Viji serves as Managing Director 3, supported by G. Shankar as Executive Director & CFO 4 and R. Madhusudhan as Director, Corporate Affairs & HR 5. The board currently comprises 8 members — 3 Executive and 5 Non-Executive directors, all classified as Non-Promoters 1 — yielding a non-executive majority that provides structural oversight of management. Board engagement is substantive: 6 meetings were convened during the financial year with director attendance ranging from 83% to 100% 8. Governance is operationalised through six specialised committees covering sustainability, remuneration, internal controls, CSR, health and safety, and POSH 7, indicating institutional breadth beyond statutory minimums. The committee architecture, combined with a non-executive majority, positions the board to provide credible checks on capital allocation as the company executes its global expansion agenda 11.

Brakes India presents a compelling investment case as India's dominant braking systems supplier, combining entrenched OEM relationships, a near-pristine balance sheet, and a deliberate pivot into advanced electro-mechanical and drivetrain technologies that extend its addressable market well beyond conventional braking.

Three structural strengths anchor the thesis. First, market leadership is durable: the company holds leading share with domestic OEMs across commercial vehicles, tractors, and passenger cars, supplying Tata Motors, Ashok Leyland, Maruti Suzuki, and Mahindra & Mahindra 12, underpinned by a CRISIL AA+/Stable credit rating 10 and CRISIL's own expectation of 7–9% medium-term revenue growth driven by aftermarket and export expansion 11. Second, financial quality is exceptional: revenue reached ₹7,499 Cr in FY2025 1 on a 12.3% three-year CAGR 2, with PAT compounding at 22.8% over the same period 8, a debt-to-equity ratio of 0.10x 7, and interest coverage of 17.5x 6. Third, technology positioning is proactive: Brakes India has localised India's first Electric Parking Brake 14 and formed a greenfield JV with ADVICS to develop Electronic Stability Control, backed by a combined investment of over INR 500 crore 17.

Near-term catalysts are concrete. The December 2025 capital alliance with Japan's TBK opens new export markets for hydraulic and pneumatic products 19. The January 2026 launch of the Revia clutch line extends the company into drivetrain components 20. Management's optimistic FY26–27 outlook, citing rising vehicle volumes and improving segment mix 22, alongside a committed ₹1,000 crore capacity investment programme by 2030 15, positions the company for accelerating revenue conversion as India's safety and electrification regulatory cycle tightens 21.

Brakes India's principal risks centre on customer-segment cyclicality and geographic export concentration, with a credible but manageable downside scenario given the company's near-zero leverage position.

The most immediate risk is M&HCV cyclicality: the brakes division derives approximately 25% of revenue from commercial vehicles 7, the segment historically exhibiting the sharpest demand swings, including a pronounced industry slowdown in 2018–19 16. Compounding this, exports — representing 23% of total group revenue — are concentrated, with approximately 75% of that export turnover sourced from Europe 89. Any significant demand weakness from the European region will constrain the pace of growth in the export business 10, as demonstrated during the Russia-Ukraine-driven volatility in early 2022.

The technology transition to EV platforms poses a medium-term structural risk. The shift from traditional friction braking to regenerative braking systems requires R&D investments and manufacturing adaptation 13, and market growth is partly dependent on the trajectory of regulatory support 17. Post the dissolution of the 60-year ZF partnership, the company acknowledged prior technology dependency for certain product lines, and is now reliant on in-house R&D to fill that gap 14.

In a downside scenario — simultaneous European demand contraction and a domestic M&HCV downcycle — CRISIL's defined threshold of operating margin compression below 8–9% on a sustained basis 11 would signal material credit deterioration. With an EBITDA margin of 13.6% in FY2025 4 and net debt-to-EBITDA at 0.0x 3, the current buffer is substantial, but an elevated capex-to-revenue of 4.9% in FY2025 5 narrows free cash flow headroom should revenue stall. The CRISIL leverage trigger of debt/EBITDA exceeding 2.75–3x 12 remains a distant but relevant constraint if the capex cycle accelerates into a weaker demand environment.

Concentration risks have been partially addressed: CV braking capacity has been redistributed with 30–40% of volume shifted from the Sholingur facility to Jamshedpur 15, reducing single-facility exposure. The residual risk profile warrants close monitoring of European automotive production data and domestic CV registration trends as leading indicators.